Molecular Determinants of Immunotherapy Efficacy in Mesothelioma: A Step Toward Precision Oncology

Affiliations

• ¹ Cancer Biology Program, University of Hawaii Cancer Center, Honolulu, Hawaii. Electronic address: haining@hawaii.edu.
• ² Division of Hematology-Oncology, Department of Medicine, Jonsson Comprehensive Cancer Center and Parker Institute for Cancer Immunotherapy, University of California, Los Angeles, Los Angeles, California; Division of Surgical Oncology, Department of Surgery, Jonsson Comprehensive Cancer Center and Parker Institute for Cancer Immunotherapy, University of California, Los Angeles, Los Angeles, California; Department of Molecular and Medical Pharmacology, Jonsson Comprehensive Cancer Center and Parker Institute for Cancer Immunotherapy, University of California, Los Angeles, Los Angeles, California.